GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Omni Health OMHE · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

About Omni Health

Its shares trade under the ticker OMHE. It has been listed since 6 January 2015. In the fiscal year to 30 April 2017, it reported revenue of $4.7m and net income of $1.3m. At that date it held total assets of $5.5m and shareholders' equity of $3.6m.

Omni Health, Inc. engages in the provision of health, wellness, and pharmacy services through its pharmacy. The company is headquartered in Hialeah, Florida. The company went IPO on 2015-01-06. The firm is focused on the development of pharmaceuticals, anti-aging products, and biotech engineering. The Company’s subsidiary is Malecon Pharmacy, Inc., which is engaged in healthcare services and operates in the lucrative pharmaceutical, medical and wellness industries.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
6 Jan 2015

Leadership

Pay as last reported

  • Mr. Andrey SolovievChief Executive Officer, Interim Chief Financial Officer, Director, since 2016
  • Dr. Khary BryanChief Technology Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Omni Health Inc's Malecon Pharmacy operates in the lucrative pharmaceutical industry in Hialeah, Florida.
  • The company's focus on pharmaceuticals, anti-aging products, and biotech engineering drives innovation.
  • Omni Health's subsidiary Malecon Pharmacy, Inc. serves the healthcare services segment effectively.

Weaknesses

  • The company's headquarters in Hialeah, Florida, limits its market reach compared to larger cities.
  • Omni Health's reliance on a single subsidiary Malecon Pharmacy may pose operational risks.
  • The firm's focus on niche markets like anti-aging products could restrict broader market appeal.

Opportunities

  • Expanding into the growing anti-aging product market in the US healthcare sector.
  • Increasing demand for biotech engineering solutions in the pharmaceutical industry.
  • Potential growth in the wellness industry through Malecon Pharmacy's services.

Threats

  • Competition from established pharmaceutical companies in the US market.
  • Regulatory changes affecting the healthcare and pharmaceutical industries.
  • Economic downturns impacting consumer spending on wellness services.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.